1. Home
  2. BCAB vs MNTX Comparison

BCAB vs MNTX Comparison

Compare BCAB & MNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • MNTX
  • Stock Information
  • Founded
  • BCAB 2007
  • MNTX 1993
  • Country
  • BCAB United States
  • MNTX United States
  • Employees
  • BCAB N/A
  • MNTX N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • MNTX Industrial Machinery/Components
  • Sector
  • BCAB Health Care
  • MNTX Technology
  • Exchange
  • BCAB Nasdaq
  • MNTX Nasdaq
  • Market Cap
  • BCAB 91.4M
  • MNTX 77.7M
  • IPO Year
  • BCAB 2020
  • MNTX 2005
  • Fundamental
  • Price
  • BCAB $1.68
  • MNTX $5.62
  • Analyst Decision
  • BCAB Strong Buy
  • MNTX Buy
  • Analyst Count
  • BCAB 3
  • MNTX 2
  • Target Price
  • BCAB $8.67
  • MNTX $6.90
  • AVG Volume (30 Days)
  • BCAB 571.3K
  • MNTX 482.2K
  • Earning Date
  • BCAB 11-05-2024
  • MNTX 10-31-2024
  • Dividend Yield
  • BCAB N/A
  • MNTX N/A
  • EPS Growth
  • BCAB N/A
  • MNTX N/A
  • EPS
  • BCAB N/A
  • MNTX 0.53
  • Revenue
  • BCAB N/A
  • MNTX $299,562,000.00
  • Revenue This Year
  • BCAB N/A
  • MNTX $6.97
  • Revenue Next Year
  • BCAB N/A
  • MNTX $12.08
  • P/E Ratio
  • BCAB N/A
  • MNTX $10.69
  • Revenue Growth
  • BCAB N/A
  • MNTX 5.01
  • 52 Week Low
  • BCAB $1.14
  • MNTX $3.07
  • 52 Week High
  • BCAB $4.02
  • MNTX $9.16
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 45.55
  • MNTX 71.54
  • Support Level
  • BCAB $1.72
  • MNTX $3.68
  • Resistance Level
  • BCAB $1.85
  • MNTX $5.64
  • Average True Range (ATR)
  • BCAB 0.13
  • MNTX 0.14
  • MACD
  • BCAB -0.02
  • MNTX 0.23
  • Stochastic Oscillator
  • BCAB 10.34
  • MNTX 98.54

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About MNTX Manitex International Inc.

Manitex International Inc through its subsidiaries is engaged in the design, manufacture, and distribution of engineered lifting solutions. Its products include boom trucks, truck cranes, and sign cranes. The company's segments include Lifting Equipment and Rental Equipment. It generates maximum revenue from the Lifting Equipment segment. Geographically, it derives majority of its revenue from the United States.

Share on Social Networks: